Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $10,990,762 |
Sells | 121 | $9,707,840 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
30 Sep 2022 16:05 | ALVR | Allovir Inc | HALLAL DAVID | Director , 10% | 29 Sep 2022 | Sale | 400,000 | 7.3523 | 2,940,920 | I |
21 Oct 2022 21:30 | ALVR | Allovir Inc | HALLAL DAVID | Director , 10% | 19 Oct 2022 | Sale | 600,000 | 8.45 | 5,070,000 | I |
24 Oct 2022 18:23 | ALVR | Allovir Inc | ATILLASOY ERCEM | See Remarks | 20 Oct 2022 | Sale | 1,527 | 8.4843 | 12,956 | D |
24 Oct 2022 18:23 | ALVR | Allovir Inc | ATILLASOY ERCEM | See Remarks | 19 Oct 2022 | Sale | 568 | 9.3607 | 5,317 | D |
24 Oct 2022 18:24 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 19 Oct 2022 | Sale | 553 | 9.3607 | 5,176 | D |
24 Oct 2022 18:25 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 24 Oct 2022 | Sale | 2,000 | 8.1345 | 16,269 | D |
24 Oct 2022 18:25 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 21 Oct 2022 | Sale | 11,334 | 8.4524 | 95,800 | D |
24 Oct 2022 18:25 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 19 Oct 2022 | Sale | 345 | 9.3607 | 3,229 | D |
24 Oct 2022 18:26 | ALVR | Allovir Inc | VAN BEEK JEROEN B | Chief Commercial Officer | 19 Oct 2022 | Sale | 1,070 | 9.3607 | 10,016 | D |
24 Oct 2022 18:28 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 19 Oct 2022 | Sale | 1,449 | 9.3607 | 13,564 | D |
26 Oct 2022 16:15 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 20 Oct 2022 | Sale A | 1,449 | 9.3607 | 13,564 | D |
26 Oct 2022 16:15 | ALVR | Allovir Inc | VAN BEEK JEROEN B | Chief Commercial Officer | 20 Oct 2022 | Sale A | 1,070 | 9.3607 | 10,016 | D |
26 Oct 2022 16:15 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 20 Oct 2022 | Sale A | 345 | 9.3607 | 3,229 | D |
26 Oct 2022 16:15 | ALVR | Allovir Inc | ATILLASOY ERCEM | See Remarks | 21 Oct 2022 | Sale A | 1,527 | 8.4843 | 12,956 | D |
26 Oct 2022 16:15 | ALVR | Allovir Inc | ATILLASOY ERCEM | See Remarks | 20 Oct 2022 | Sale A | 568 | 9.3607 | 5,317 | D |
26 Oct 2022 16:15 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 20 Oct 2022 | Sale A | 553 | 9.3607 | 5,176 | D |
10 Nov 2022 17:29 | ALVR | Allovir Inc | VAN BEEK JEROEN B | Chief Commercial Officer | 10 Nov 2022 | Sale | 13,109 | 8.0022 | 104,901 | D |
10 Nov 2022 17:29 | ALVR | Allovir Inc | VAN BEEK JEROEN B | Chief Commercial Officer | 08 Nov 2022 | Sale | 299 | 8 | 2,392 | D |
14 Nov 2022 17:06 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 11 Nov 2022 | Sale | 18,011 | 8.176 | 147,258 | D |
14 Nov 2022 17:06 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 10 Nov 2022 | Sale | 5,989 | 8.0021 | 47,925 | D |
15 Nov 2022 16:53 | ALVR | Allovir Inc | VAN BEEK JEROEN B | Chief Commercial Officer | 11 Nov 2022 | Sale | 36,592 | 8.1959 | 299,904 | D |
16 Nov 2022 17:10 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 14 Nov 2022 | Sale | 2,358 | 8.9135 | 21,018 | I |
18 Nov 2022 16:05 | ALVR | Allovir Inc | VAN BEEK JEROEN B | Chief Commercial Officer | 16 Nov 2022 | Sale | 16,074 | 7.4983 | 120,528 | D |
21 Nov 2022 17:47 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 18 Nov 2022 | Sale | 4,515 | 7.2669 | 32,810 | D |
23 Jan 2023 19:00 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 19 Jan 2023 | Sale | 34,435 | 5.0777 | 174,851 | D |
23 Jan 2023 19:00 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 20 Jan 2023 | Sale | 338 | 5.1438 | 1,739 | D |
23 Jan 2023 19:00 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 19 Jan 2023 | Sale | 1,557 | 5.0777 | 7,906 | D |
23 Jan 2023 19:00 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 20 Jan 2023 | Sale | 541 | 5.1438 | 2,783 | D |
23 Jan 2023 19:00 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 19 Jan 2023 | Sale | 2,032 | 5.0777 | 10,318 | D |
23 Jan 2023 19:00 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 20 Jan 2023 | Sale | 1,426 | 5.1438 | 7,335 | D |
23 Jan 2023 19:00 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 19 Jan 2023 | Sale | 5,111 | 5.0777 | 25,952 | D |
23 Feb 2023 17:00 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 21 Feb 2023 | Sale | 5,122 | 6.6254 | 33,935 | D |
21 Apr 2023 16:05 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 19 Apr 2023 | Sale | 8,408 | 3.7087 | 31,183 | D |
21 Apr 2023 16:05 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 20 Apr 2023 | Sale | 349 | 3.6255 | 1,265 | D |
21 Apr 2023 16:05 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 19 Apr 2023 | Sale | 348 | 3.7087 | 1,291 | D |
21 Apr 2023 16:05 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 20 Apr 2023 | Sale | 1,466 | 3.6255 | 5,315 | D |
21 Apr 2023 16:05 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 19 Apr 2023 | Sale | 1,217 | 3.7087 | 4,513 | D |
19 May 2023 17:00 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 18 May 2023 | Sale | 4,536 | 4.214 | 19,115 | D |
13 Jun 2023 17:00 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 09 Jun 2023 | Sale | 5,045 | 5.6398 | 28,453 | D |
28 Jun 2023 17:17 | ALVR | Allovir Inc | GILEAD SCIENCES, INC. | 10% | 27 Jun 2023 | Purchase | 2,930,870 | 3.75 | 10,990,762 | D |
06 Jul 2023 17:00 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 05 Jul 2023 | Sale | 2,983 | 3.0451 | 9,084 | D |
06 Jul 2023 17:00 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 05 Jul 2023 | Sale | 5,275 | 3.0451 | 16,063 | D |
21 Jul 2023 17:00 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 20 Jul 2023 | Sale | 1,437 | 3.3474 | 4,810 | D |
21 Jul 2023 17:00 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 19 Jul 2023 | Sale | 1,198 | 3.5615 | 4,267 | D |
21 Jul 2023 17:00 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 20 Jul 2023 | Sale | 342 | 3.3474 | 1,145 | D |
21 Jul 2023 17:00 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 19 Jul 2023 | Sale | 342 | 3.5615 | 1,218 | D |
21 Jul 2023 17:00 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 19 Jul 2023 | Sale | 8,342 | 3.5615 | 29,710 | D |
21 Aug 2023 17:00 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 17 Aug 2023 | Sale | 1,653 | 2.4955 | 4,125 | D |
21 Aug 2023 17:00 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 18 Aug 2023 | Sale | 4,055 | 2.7898 | 11,313 | D |
21 Aug 2023 17:00 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 17 Aug 2023 | Sale | 11,361 | 2.4955 | 28,351 | D |
21 Aug 2023 17:00 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 17 Aug 2023 | Sale | 10,516 | 2.4955 | 26,243 | D |
05 Oct 2023 17:00 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 03 Oct 2023 | Sale | 222 | 1.9763 | 439 | D |
05 Oct 2023 17:00 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 03 Oct 2023 | Sale | 755 | 1.9763 | 1,492 | D |
05 Oct 2023 17:00 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 03 Oct 2023 | Sale | 1,325 | 1.9763 | 2,619 | D |
23 Oct 2023 17:00 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 20 Oct 2023 | Sale | 1,475 | 1.541 | 2,273 | D |
23 Oct 2023 17:00 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 19 Oct 2023 | Sale | 1,232 | 1.58 | 1,947 | D |
23 Oct 2023 17:00 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 19 Oct 2023 | Sale | 8,581 | 1.58 | 13,558 | D |
23 Oct 2023 17:00 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 20 Oct 2023 | Sale | 357 | 1.541 | 550 | D |
23 Oct 2023 17:00 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 19 Oct 2023 | Sale | 358 | 1.58 | 566 | D |
21 Nov 2023 17:00 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 17 Nov 2023 | Sale | 403 | 1.6311 | 657 | D |
21 Nov 2023 17:00 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 20 Nov 2023 | Sale | 4,382 | 1.6905 | 7,408 | D |
21 Nov 2023 17:00 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 17 Nov 2023 | Sale | 2,689 | 1.6311 | 4,386 | D |
21 Nov 2023 17:00 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 17 Nov 2023 | Sale | 2,490 | 1.6311 | 4,061 | D |
02 Jan 2024 19:36 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 27 Dec 2023 | Sale | 28,335 | 0.7354 | 20,838 | D |
08 Jan 2024 16:15 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 04 Jan 2024 | Sale | 1,664 | 0.639 | 1,063 | D |
08 Jan 2024 16:15 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 04 Jan 2024 | Sale | 961 | 0.639 | 614 | D |
08 Jan 2024 16:15 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 04 Jan 2024 | Sale | 424 | 0.639 | 271 | D |
08 Jan 2024 16:15 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 04 Jan 2024 | Sale | 310 | 0.639 | 198 | D |
25 Jan 2024 16:15 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 23 Jan 2024 | Sale | 1,302 | 0.6708 | 873 | D |
25 Jan 2024 16:15 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 23 Jan 2024 | Sale | 901 | 0.6708 | 604 | D |
25 Jan 2024 16:15 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 23 Jan 2024 | Sale | 9,500 | 0.6704 | 6,369 | D |
25 Jan 2024 16:15 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 23 Jan 2024 | Sale | 3,205 | 0.6708 | 2,150 | D |
06 Feb 2024 16:38 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 05 Feb 2024 | Sale | 41,421 | 0.67 | 27,752 | D |
06 Feb 2024 16:39 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 05 Feb 2024 | Sale | 5,792 | 0.67 | 3,881 | D |
06 Feb 2024 16:40 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 05 Feb 2024 | Sale | 8,869 | 0.67 | 5,942 | D |
06 Feb 2024 16:46 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 05 Feb 2024 | Sale | 18,331 | 0.67 | 12,282 | D |
09 Feb 2024 20:01 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 08 Feb 2024 | Sale | 11,150 | 0.6721 | 7,494 | D |
22 Feb 2024 16:15 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 20 Feb 2024 | Sale | 494 | 0.6952 | 343 | D |
22 Feb 2024 16:15 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 20 Feb 2024 | Sale | 2,893 | 0.6952 | 2,011 | D |
22 Feb 2024 16:16 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 20 Feb 2024 | Sale | 385 | 0.6952 | 268 | D |
22 Feb 2024 16:18 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 21 Feb 2024 | Sale | 5,155 | 0.7081 | 3,650 | D |
22 Feb 2024 16:18 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 20 Feb 2024 | Sale | 3,097 | 0.6952 | 2,153 | D |
04 Apr 2024 16:15 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 02 Apr 2024 | Sale | 885 | 0.772 | 683 | D |
04 Apr 2024 16:15 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 02 Apr 2024 | Sale | 281 | 0.772 | 217 | D |
04 Apr 2024 16:15 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 02 Apr 2024 | Sale | 1,533 | 0.772 | 1,183 | D |
04 Apr 2024 16:15 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 02 Apr 2024 | Sale | 368 | 0.772 | 284 | D |
23 Apr 2024 16:15 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 22 Apr 2024 | Sale | 1,857 | 0.75 | 1,393 | D |
23 Apr 2024 16:15 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 19 Apr 2024 | Sale | 1,521 | 0.7506 | 1,142 | D |
23 Apr 2024 16:15 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 19 Apr 2024 | Sale | 9,601 | 0.7506 | 7,207 | D |
23 Apr 2024 16:15 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 22 Apr 2024 | Sale | 757 | 0.75 | 568 | D |
23 Apr 2024 16:15 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 19 Apr 2024 | Sale | 626 | 0.7506 | 470 | D |
23 Apr 2024 16:15 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 22 Apr 2024 | Sale | 480 | 0.75 | 360 | D |
23 Apr 2024 16:15 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 19 Apr 2024 | Sale | 473 | 0.7506 | 355 | D |
07 May 2024 16:15 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 03 May 2024 | Sale | 2,311 | 0.796 | 1,840 | D |
07 May 2024 16:15 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 03 May 2024 | Sale | 4,957 | 0.796 | 3,946 | D |
07 May 2024 16:15 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 03 May 2024 | Sale | 1,597 | 0.796 | 1,271 | D |
07 May 2024 16:15 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 03 May 2024 | Sale | 10,240 | 0.796 | 8,151 | D |
21 May 2024 16:33 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 17 May 2024 | Sale | 420 | 0.7493 | 315 | D |
21 May 2024 16:33 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 17 May 2024 | Sale | 3,143 | 0.7493 | 2,355 | D |
21 May 2024 16:35 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 17 May 2024 | Sale | 3,075 | 0.7493 | 2,304 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)